Satellos Bioscience Inc. (MSCLF)
(Delayed Data from OTC)
$0.40 USD
0.00 (0.00%)
Updated Aug 30, 2024 09:59 AM ET
NA Value
NA Growth NA Momentum NA VGMSatellos Bioscience (MSCLF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.00 | $1.00 | $1.00 | 150.00% |
Price Target
Only one analyst offered a short-term price target of $1.00 for Satellos Bioscience. This represents an increase of 150% from the last closing price of $0.40.
Analyst Price Targets (1 )
Broker Rating
Satellos Bioscience does not currently have any recommendation from brokerage firms.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | NA | NA | NA | NA | NA |
Buy | NA | NA | NA | NA | NA |
Hold | NA | NA | NA | NA | NA |
Sell | NA | NA | NA | NA | NA |
Strong Sell | NA | NA | NA | NA | NA |
ABR | NA | NA | NA | NA | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | NA |
ABR (Last week) | NA |
# of Recs in ABR | NA |
Average Target Price | $1.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 81 of 253 |
Current Quarter EPS Est: | -0.05 |